Project Grant HT94252510064
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
The Virginia Commonwealth University will receive $1.5 million over four years from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to manage distress in malignant brain cancer. Through this Project Grant award issued on August 1, 2021 and concluding on July 31, 2025, VCU will provide services to transform healthcare for service members and the public through innovative research investigating medical solutions for the...
This federal Project Grant award in the amount of $582,189.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Virginia Commonwealth University (VCU) to investigate the role of histone H2A ubiquitination and the RSF1 gene in breast cancer. The 3-year award, starting on March 1, 2024, will fund personnel, facilities, and equipment to conduct basic, translational, and clinical research aimed at advancing...
The Virginia Commonwealth University (VCU) was awarded a $799,338 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering under the Basic, Applied, and Advanced Research in Science and Engineering federal grant program (CFDA 12.630). The four-year award beginning June 1, 2023 will fund VCU research personnel, facilities, and equipment to conduct studies and develop technologies with potential to contribute to...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $378,260.00 in funding to Virginia Commonwealth University (VCU) from February 1, 2024 to January 31, 2026 for the project "GENE THERAPY IN EXPERIMENTAL HYDROCEPHALUS." The award supports VCU's biomedical research on developing gene therapy treatments for hydrocephalus, a condition involving abnormal accumulation of cerebrospinal fluid in the brain....
The Virginia Commonwealth University (VCU) was awarded a $768,002 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering fields from June 5, 2023 through June 4, 2027. The grant funds VCU research under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630), which supports research with potential to contribute to Department of Defense technology. VCU researchers will conduct...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
The federal Project Grant award of $1,788,135.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant aims to support advanced biomedical research to "TARGET GANGLIOSIDE GD2 TO OVERCOME CHEMOTHERAPY RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER" over the project period from Sep 1, 2025 to Aug 31, 2029. The award was granted to Virginia Commonwealth University, a public research university that has demonstrated...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $249,732 in funding to Virginia Commonwealth University (VCU) for research on novel kappa opioid receptor (KOR) agonists and their potential to promote central nervous system (CNS) repair. The award, which runs from September 1, 2024 to August 31, 2025, will enable VCU to conduct research aimed at developing effective treatments for...